AstraZeneca is fined by South Korea for an anticompetitive deal over a cancer drug; Flush with cash, BioNTech founders have outsized ambitions

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: AstraZeneca is fined by South Korea for an anticompetitive deal over a cancer drug By Ed Silverman Adobe This is the latest instance in which a global pharmaceutical company has been cited for anticompetitive behavior. Read More STAT+: Flush with cash from Covid-19 vaccine, BioNTech founders have outsized ambitions By Matthew Herper Matthew Herper/STAT “We will use the chance – this historic chance – to build a global pharmaceutical company,” said BioNTech CEO Ugur Sahin. Read More STAT+: Relmada antidepressant drug fails first of several late-stage clinical trials By Adam Feuerstein APStock The drug, a pill called REL-1017, did not show a statistically significant, anti-depressive benefit compared with a placebo. Read More Sponsor content by AWS MARKETPLACE Collecting and harmonizing real-world data Join this webinar to hear from data leaders at AWS, Qiagen, TriNetX and Prognos, as they discuss how Real-World data is integral to ensuring patient health including top use cases being seen in biopharma, and how technology will play a role in RWD over the next 5 years. Register now. Opinion: Why the U.S. needs a public benefit biopharma industry By Barbara Handelin and Sandra Heibel Adobe Biopharma is failing Americans, both medically and economically. We need a public benefit biopharma industry. Read More STAT+: Alphabet's AI predicted the structure of 200 million proteins. Can it really speed up drug discovery? By Brittany Trang Courtesy DeepMind AlphaFold’s ingenious application of AI will result in steady advances, but this does not unlock hyperspeed in the quest for cures. Read More Thursday, October 13, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser